Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report ; volume:16 ; number:1 ; day:9 ; month:11 ; year:2017 ; pages:1-9 ; date:12.2017
Cardiovascular diabetology ; 16, Heft 1 (9.11.2017), 1-9, 12.2017
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Kim, Kyoung Min
- Beteiligte Personen und Organisationen
-
Jung, Kyong Yeun
Yun, Han Mi
Lee, Seo Young
Oh, Tae Jung
Jang, Hak Chul
Lim, Soo
SpringerLink (Online service)
- DOI
-
10.1186/s12933-017-0629-0
- URN
-
urn:nbn:de:1111-2018010718464
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Kyoung Min
- Jung, Kyong Yeun
- Yun, Han Mi
- Lee, Seo Young
- Oh, Tae Jung
- Jang, Hak Chul
- Lim, Soo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
Fasting remnant lipoproteins can predict postprandial hyperlipidemia
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects
Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions
Erratum to: fasting remnant lipoproteins can predict postprandial hyperlipidemia
Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR‐92a Levels in Humans
Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents
Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status
Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values
Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
Fasting remnant lipoproteins can predict postprandial hyperlipidemia
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects
Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions
Erratum to: fasting remnant lipoproteins can predict postprandial hyperlipidemia
Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR‐92a Levels in Humans
Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents
Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status
Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values
Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
Fasting remnant lipoproteins can predict postprandial hyperlipidemia
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects
Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions
Erratum to: fasting remnant lipoproteins can predict postprandial hyperlipidemia
Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR‐92a Levels in Humans
Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents
Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status